© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 16, 2021
Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.
September 13, 2021
There are many substances that are included on the prohibited list for the Tokyo Olympics that are considered standard medications for certain disease states.
September 10, 2021
The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.
September 09, 2021
The results of a new study show that when coronavirus-infected diabetic mice were injected with an interferon beta, SETDB2 increased and helped decrease the inflammatory cytokines.
September 07, 2021
Diabetic kidney disease develops in nearly 40% of patients with diabetes and serves as the leading cause of chronic kidney disease worldwide, according to the study.
September 01, 2021
Peptides that cause migraine pain can influence insulin production in mice, possibly by regulating the amount of secreted insulin or by increasing the number of pancreatic cells that produce it.
August 30, 2021
In addition to early screening, counseling patients on preventive interventions can reduce the risk of developing prediabetes or type 2 diabetes.
August 19, 2021
According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.
August 17, 2021
Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.
August 16, 2021
The expanded indication follows Lyumjev’s original approval in 2020 and offers an important new delivery mechanism for patients with diabetes.